Extended Remdesivir Infusion Combined With Nirmatrelvir/Ritonavir for Persistent SARS-CoV-2 Infection in Immunocompromised Patients
Clinical trial NCT06610643 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06610643
- Sponsor
- National Taiwan University Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-21
- Primary completion
- 2026-09-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.